1. Adelaide Research & Scholarship

Search


Current filters:


Start a new search
Add filters:

Use filters to refine the search results.

 | 
Results 1-10 of 10 (Search time: 0.003 seconds).
  • previous
  • 1
  • next
Item hits:
PreviewIssue DateTitleAuthor(s)
2003Paroxetine in major depressionJureidini, J.; Tonkin, A.
1999Evaluation of the dose-response relationship for intra-nasal oxymetazoline hydrochloride in normal adultsTaverner, D.; Bickford, L.; Shakib, S.; Tonkin, A.
2012Antidepressant-like effects of ecstasy in subjects with a predisposition to depressionMajumder, I.; White, J.; Irvine, R.
2005Short-term outcomes of five heroin detoxification methods in the Australian NEPOD projectDigiusto, E.; Lintzeris, N.; Breen, C.; Kimber, J.; Mattick, R.; Bell, J.; Ali, R.; Saunders, J.
2010Effect of CYP2B6, ABCB1, and CYP3A5 polymorphisms on efavirenz pharmacokinetics and treatment response: an AIDS Clinical Trials Group studyRibaudo, H.; Liu, H.; Schwab, M.; Schaeffeler, E.; Eichelbaum, M.; Motsinger-Reif, A.; Ritchie, M.; Zanger, U.; Acosta, E.; Morse, G.; Gulick, R.; Robbins, G.; Clifford, D.; Haas, D.
2005The characteristics of heroin users entering treatment: findings from the Australian Treatment Outcome Study (ATOS)Ross, J.; Teesson, M.; Darke, S.; Lynskey, M.; Ali, R.; Ritter, A.; Cooke, R.
2008Enhanced buprenorphine analgesia with the addition of ultra-low-dose naloxone in healthy subjectsLa Vincente, S.; White, J.; Somogyi, A.; Bochner, F.; Chapleo, C.
2005Factors associated with 12 months continuous heroin abstinence: findings from the Australian Treatment Outcome Study (ATOS)Darke, S.; Ross, J.; Teesson, M.; Ali, R.; Cooke, R.; Ritter, A.; Lynskey, M.
2012The effects of pregabalin and the glial attenuator minocycline on the response to intradermal capsaicin in patients with unilateral sciaticaSumracki, N.; Hutchinson, M.; Gentgall, M.; Briggs, N.; Williams, D.; Rolan, P.; Ikeda, K.
2016Antiretroviral resistance at virological failure in the NEAT 001/ANRS 143 trial: raltegravir plus darunavir/ritonavir or tenofovir/emtricitabine plus darunavir/ritonavir as first-line ARTLambert-Niclot, S.; George, E.; Pozniak, A.; White, E.; Schwimmer, C.; Jessen, H.; Johnson, M.; Dunn, D.; Perno, C.; Clotet, B.; Plettenberg, A.; Blaxhult, A.; Palmisano, L.; Wittkop, L.; Calvez, V.; Marcelin, A.; Raffi, F.; Dedes, N.; Chěne, G.; Allavena, C.; et al.

Discover